Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Cortech regains rights to elastase inhibitor

Dec. 20, 1996

Schering-Plough reveals new NK antagonists

Dec. 20, 1996

5-LO inhibitor under evaluation at SKB

Dec. 19, 1996

Dual-action compounds claimed by British Biotech

Dec. 17, 1996

Antiallergic/antiasthmatic compounds disclosed by Dainippon Ink

Dec. 16, 1996

New antitussive agent from Snow Brand Milk Products

Dec. 16, 1996

5-LO inhibitor approved by FDA

Dec. 13, 1996

Abbott reports on new PAF antagonists

Dec. 13, 1996

NK1 antagonists described by Boehringer Ingelheim

Dec. 13, 1996

Daiichi claims LTD4 antagonists for treating allergic diseases

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026